Groupe IRD Stock

Groupe IRD Equity

Delisted

The The Equity of Groupe IRD (IRD.PA) as of Aug 19, 2026 is 124.59 M EUR. In the previous year, The Equity was 111.72 M EUR — a change of 11.51% (higher).

Equity

124.59 MEUR

YoY

11.51%

Last updated:

In 2026, Groupe IRD's equity was 124.59 M EUR, a 11.51% increase from the 111.72 M EUR equity in the previous year.

Access this data via the Eulerpool API

Groupe IRD Stock analysis

What does Groupe IRD do? Groupe IRD SA is an internationally active company specializing in the development and production of medical diagnostics and food tests. The company's history dates back over 70 years, when it was founded by Dr. Paul Dettwiler in 1949. Since then, the company has grown from a small laboratory to a world-leading provider of tests for medicine and food safety. Groupe IRD SA's business model is based on innovative technologies, product quality, and customer orientation. The company has various business divisions that focus on the different needs of its customers. The diagnostic division is involved in the manufacture and distribution of medical tests for laboratory diagnostics, particularly for infectious diseases such as HIV, hepatitis, or tuberculosis. IRD offers a comprehensive range of tests, ranging from simple rapid tests to advanced diagnostic platforms. Another important area of Groupe IRD SA is food safety. The company develops and produces fast, reliable, and precise tests to examine a variety of foods for potential contaminants such as pesticides, antibiotics, or allergens. These tests are used in both food production facilities and by authorities. IRD is also a major manufacturer of test kits for animal health. These include tests for the early detection of infectious diseases such as brucellosis or paratuberculosis. Veterinarians and farmers use these tests to protect their herds from disease outbreaks. In addition to the three core areas, IRD also operates an extensive service program that provides assistance to its customers in setting up laboratories and conducting training in test handling. The company strives to work closely with its customers to understand their needs and offer them the best possible products and services. Innovation and research play a major role in the corporate philosophy of Groupe IRD SA. The company continuously invests in the development of new products and technologies and is always seeking to improve its existing products. IRD also places great importance on sustainable and environmentally friendly production, and strives to minimize its ecological footprint. Overall, Groupe IRD SA has become an internationally active company with nearly 200 employees and operates in over 100 countries worldwide. The company has earned an excellent reputation as a reliable manufacturer of diagnostic and food test kits and is constantly striving to improve its products and satisfy its customers. Groupe IRD is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Groupe IRD's Equity

Groupe IRD's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Groupe IRD's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Groupe IRD's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Groupe IRD's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Groupe IRD’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Groupe IRD stock

The Equity of Groupe IRD is 124.59 M EUR in 2026.

The Equity of Groupe IRD changed from 111.72 M EUR to 124.59 M EUR, representing a 11.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Groupe IRD since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Groupe IRD historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Groupe IRD

All Key Metrics — Groupe IRD